Antibody-platinum (IV) prodrugs conjugates for targeted treatment of cutaneous squamous cell carcinoma

Antibody-platinum (IV) prodrugs conjugates for targeted treatment of cutaneous squamous cell carcinoma

Antibody-drug conjugates (ADCs) are a new type of targeting antibodies that conjugate with highly toxic anticancer drugs via chemical linkers to exert high specificity and efficient killing of tumor cells, thereby attracting considerable attention in precise oncology therapy. Cetuximab (Cet) is a ty...

Full description

Bibliographic Details
Main Authors:	Xiangye Yin, Yingjie Zhuang, Haiqin Song, Yujian Xu, Fan Zhang, Jianxin Cui, Lei Zhao, Yingjie Yu, Qixu Zhang, Jun Ye, Youbai Chen, Yan Han
Format:	Article
Language:	English
Published:	Elsevier 2024-03-01
Series:	Journal of Pharmaceutical Analysis
Subjects:	Antibody drug conjugate Cutaneous squamous cell carcinoma DNA damage Platinum drug Targeted therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2095177923002678

Similar Items

Disulfide-containing polymer delivery of C527 and a Platinum(IV) prodrug selectively inhibited protein ubiquitination and tumor growth on cisplatin resistant and patient-derived liver cancer models
by: Kun Shang, et al.
Published: (2023-02-01)

Mesoporous Silica Nanoparticles Enhance the Anticancer Efficacy of Platinum(IV)-Phenolate Conjugates in Breast Cancer Cell Lines
by: Ivana Predarska, et al.
Published: (2022-10-01)

Lipid-Drug Conjugates and Nanoparticles for the Cutaneous Delivery of Cannabidiol
by: Aleksandra Zielińska, et al.
Published: (2022-05-01)

Prodrug Approach: NSAID Conjugates of Platinum Compounds as Anti-Cancer Agents
by: NIJA B
Published: (2023-12-01)

Versatile Platinum(IV) Prodrugs of Naproxen and Acemetacin as Chemo-Anti-Inflammatory Agents
by: Angelico D. Aputen, et al.
Published: (2023-04-01)

Platinum(IV)-Loaded Degraded Glycol Chitosan as Efficient Platinum(IV) Drug Delivery Platform
by: Yvonne Lerchbammer-Kreith, et al.
Published: (2023-03-01)

Ligand Evolution in the Photoactivatable Platinum(IV) Anticancer Prodrugs
by: Jingjing Huang, et al.
Published: (2022-06-01)

Cyclooxygenase-Inhibiting Platinum(IV) Prodrugs with Potent Anticancer Activity
by: Aleen Khoury, et al.
Published: (2022-04-01)

Nanocarriers for platinum drug delivery
by: Qingfei Zhang, et al.
Published: (2023-06-01)

Synthesis and Validation of a Bioinspired Catechol-Functionalized Pt(IV) Prodrug for Preclinical Intranasal Glioblastoma Treatment
by: Xiaoman Mao, et al.
Published: (2022-01-01)

Identification of fatty acid metabolism–related molecular subtype biomarkers and their correlation with immune checkpoints in cutaneous melanoma
by: Yujian Xu, et al.
Published: (2022-11-01)

Potent Chlorambucil-Platinum(IV) Prodrugs
by: Angelico D. Aputen, et al.
Published: (2022-09-01)

Nectin Cell Adhesion Molecule 4 (NECTIN4) Expression in Cutaneous Squamous Cell Carcinoma: A New Therapeutic Target?
by: Yuka Tanaka, et al.
Published: (2021-03-01)

Pt(IV) Prodrugs with NSAIDs as Axial Ligands
by: Daniil Spector, et al.
Published: (2021-04-01)

Monofunctional Platinum(II) Anticancer Agents
by: Suxing Jin, et al.
Published: (2021-02-01)

A Theranostic Small-Molecule Prodrug Conjugate for Neuroendocrine Prostate Cancer
by: Paulina Gonzalez, et al.
Published: (2023-02-01)

Nanomaterial‐mediated platinum drug‐based combinatorial cancer therapy
by: Zhiqin Deng, et al.
Published: (2021-02-01)

A Novel Pyroptotic and Inflammatory Gene Signature Predicts the Prognosis of Cutaneous Melanoma and the Effect of Anticancer Therapies
by: Yujian Xu, et al.
Published: (2022-04-01)

Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma
by: Yujian Xu, et al.
Published: (2022-07-01)

Reductive prodrug and AIE copolymer nanoparticle for monitoring and chemotherapy
by: Zigui Wang, et al.
Published: (2024-03-01)

Platinum(IV) Complexes of <i>trans</i>-1,2-diamino-4-cyclohexene: Prodrugs Affording an Oxaliplatin Analogue that Overcomes Cancer Resistance
by: Paride Papadia, et al.
Published: (2020-03-01)

Nanoarchitectonics: Complexes and Conjugates of Platinum Drugs with Silicon Containing Nanocarriers. An Overview
by: Kinga Piorecka, et al.
Published: (2021-08-01)

Platinum-Based Nanoformulations for Glioblastoma Treatment: The Resurgence of Platinum Drugs?
by: Paula Alfonso-Triguero, et al.
Published: (2023-05-01)

Development of Photoremovable Linkers as a Novel Strategy to Improve the Pharmacokinetics of Drug Conjugates and Their Potential Application in Antibody–Drug Conjugates for Cancer Therapy
by: Audrey Nathania Johan, et al.
Published: (2022-05-01)

Learn from antibody–drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy
by: Mo Wu, et al.
Published: (2022-11-01)

Polyethylenimine, an Autophagy-Inducing Platinum-Carbene-Based Drug Carrier with Potent Toxicity towards Glioblastoma Cancer Stem Cells
by: Conor McCartin, et al.
Published: (2022-10-01)

Cutaneous Lymphoma and Antibody-Directed Therapies
by: Alvise Sernicola, et al.
Published: (2023-03-01)

Combination of Drug Delivery Properties of PAMAM Dendrimers and Cytotoxicity of Platinum(IV) Complexes—A More Selective Anticancer Treatment?
by: Yvonne Lerchbammer-Kreith, et al.
Published: (2023-05-01)

Current View in Platinum Drug Mechanisms of Peripheral Neurotoxicity
by: Alessia Chiorazzi, et al.
Published: (2015-08-01)

Infections of Pathogens in Lesions of Cutaneous Carcinoma
by: MAO Shiwang, et al.
Published: (2019-07-01)

Pt(IV) anticancer prodrugs and liposomal encapsulation
by: Marsh, L
Published: (2022)

Physical characteristics comparison between maytansinoid-based and auristatin-based antibody-drug conjugates
by: Tomohiro Fujii, et al.
Published: (2021-12-01)

Platinum-based Cytotoxic Drugs in Hospital Effluent, Iasfahan, Iran
by: Samineh Dehghanpour, et al.
Published: (2020-02-01)

Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment
by: Donata Galbiati, et al.
Published: (2019-12-01)

Toward Homogenous Antibody Drug Conjugates Using Enzyme-Based Conjugation Approaches
by: Ahmad Fawzi Hussain, et al.
Published: (2021-04-01)

Nanoalbumin–prodrug conjugates prepared via a thiolation‐and‐conjugation method improve cancer chemotherapy and immune checkpoint blockade therapy by promoting CD8+ T‐cell infiltration
by: Long Chen, et al.
Published: (2023-01-01)

Wireframe DNA Origami for the Cellular Delivery of Platinum(II)-Based Drugs
by: Erik De Luca, et al.
Published: (2023-11-01)

Advances in drug delivery system for platinum agents based combination therapy
by: Xiang Kang, et al.
Published: (2015-12-01)

Research Progress of Antibody–Drug Conjugate Therapy for Advanced Gastric Cancer
by: Na Wang, et al.
Published: (2022-05-01)

Revisiting Platinum-Based Anticancer Drugs to Overcome Gliomas
by: Jaewan Jeon, et al.
Published: (2021-05-01)